1-1047561-T-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_198576.4(AGRN):​c.3517-12T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.898 in 1,612,772 control chromosomes in the GnomAD database, including 659,170 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.79 ( 51070 hom., cov: 36)
Exomes 𝑓: 0.91 ( 608100 hom. )

Consequence

AGRN
NM_198576.4 intron

Scores

2
Splicing: ADA: 0.00005620
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -0.147

Publications

12 publications found
Variant links:
Genes affected
AGRN (HGNC:329): (agrin) This gene encodes one of several proteins that are critical in the development of the neuromuscular junction (NMJ), as identified in mouse knock-out studies. The encoded protein contains several laminin G, Kazal type serine protease inhibitor, and epidermal growth factor domains. Additional post-translational modifications occur to add glycosaminoglycans and disulfide bonds. In one family with congenital myasthenic syndrome affecting limb-girdle muscles, a mutation in this gene was found. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Mar 2015]
AGRN Gene-Disease associations (from GenCC):
  • congenital myasthenic syndrome 8
    Inheritance: AR Classification: STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • presynaptic congenital myasthenic syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • postsynaptic congenital myasthenic syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 1-1047561-T-C is Benign according to our data. Variant chr1-1047561-T-C is described in ClinVar as Benign. ClinVar VariationId is 263181.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.946 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AGRNNM_198576.4 linkc.3517-12T>C intron_variant Intron 20 of 35 ENST00000379370.7 NP_940978.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
AGRNENST00000379370.7 linkc.3517-12T>C intron_variant Intron 20 of 35 1 NM_198576.4 ENSP00000368678.2

Frequencies

GnomAD3 genomes
AF:
0.794
AC:
120768
AN:
152128
Hom.:
51078
Cov.:
36
show subpopulations
Gnomad AFR
AF:
0.464
Gnomad AMI
AF:
0.986
Gnomad AMR
AF:
0.883
Gnomad ASJ
AF:
0.920
Gnomad EAS
AF:
0.968
Gnomad SAS
AF:
0.947
Gnomad FIN
AF:
0.939
Gnomad MID
AF:
0.880
Gnomad NFE
AF:
0.917
Gnomad OTH
AF:
0.830
GnomAD2 exomes
AF:
0.896
AC:
223530
AN:
249388
AF XY:
0.904
show subpopulations
Gnomad AFR exome
AF:
0.447
Gnomad AMR exome
AF:
0.932
Gnomad ASJ exome
AF:
0.917
Gnomad EAS exome
AF:
0.973
Gnomad FIN exome
AF:
0.933
Gnomad NFE exome
AF:
0.913
Gnomad OTH exome
AF:
0.899
GnomAD4 exome
AF:
0.909
AC:
1328134
AN:
1460526
Hom.:
608100
Cov.:
63
AF XY:
0.912
AC XY:
662285
AN XY:
726556
show subpopulations
African (AFR)
AF:
0.439
AC:
14712
AN:
33476
American (AMR)
AF:
0.925
AC:
41382
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.914
AC:
23898
AN:
26136
East Asian (EAS)
AF:
0.970
AC:
38501
AN:
39700
South Asian (SAS)
AF:
0.943
AC:
81360
AN:
86258
European-Finnish (FIN)
AF:
0.932
AC:
48600
AN:
52126
Middle Eastern (MID)
AF:
0.851
AC:
4911
AN:
5768
European-Non Finnish (NFE)
AF:
0.918
AC:
1021024
AN:
1111962
Other (OTH)
AF:
0.890
AC:
53746
AN:
60380
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
7232
14465
21697
28930
36162
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
21450
42900
64350
85800
107250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.793
AC:
120782
AN:
152246
Hom.:
51070
Cov.:
36
AF XY:
0.798
AC XY:
59434
AN XY:
74448
show subpopulations
African (AFR)
AF:
0.463
AC:
19216
AN:
41498
American (AMR)
AF:
0.884
AC:
13530
AN:
15312
Ashkenazi Jewish (ASJ)
AF:
0.920
AC:
3194
AN:
3472
East Asian (EAS)
AF:
0.968
AC:
5006
AN:
5172
South Asian (SAS)
AF:
0.946
AC:
4570
AN:
4830
European-Finnish (FIN)
AF:
0.939
AC:
9969
AN:
10620
Middle Eastern (MID)
AF:
0.874
AC:
257
AN:
294
European-Non Finnish (NFE)
AF:
0.917
AC:
62385
AN:
68024
Other (OTH)
AF:
0.831
AC:
1756
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1013
2025
3038
4050
5063
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
840
1680
2520
3360
4200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.867
Hom.:
12044
Bravo
AF:
0.773
Asia WGS
AF:
0.922
AC:
3207
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 19, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Congenital myasthenic syndrome 8 Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
3.1
DANN
Benign
0.34
PhyloP100
-0.15
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000056
dbscSNV1_RF
Benign
0.014
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3128102; hg19: chr1-982941; API